BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32067104)

  • 1. A transcriptional metabolic gene-set based prognostic signature is associated with clinical and mutational features in head and neck squamous cell carcinoma.
    Xing L; Guo M; Zhang X; Zhang X; Liu F
    J Cancer Res Clin Oncol; 2020 Mar; 146(3):621-630. PubMed ID: 32067104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Machine Learning in Developing a Novelty Five-Pseudogene Signature to Predict Prognosis of Head and Neck Squamous Cell Carcinoma: A New Aspect of "Junk Genes" in Biomedical Practice.
    Xing L; Zhang X; Guo M; Zhang X; Liu F
    DNA Cell Biol; 2020 Apr; 39(4):709-723. PubMed ID: 32045271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
    Yang C; Mei H; Peng L; Jiang F; Xie B; Li J
    Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile analysis identifies a two-gene signature for prediction of head and neck squamous cell carcinoma patient survival.
    Xu X; Li M; Hu J; Chen Z; Yu J; Dong Y; Sun C; Han J
    J Cancer Res Ther; 2018; 14(7):1525-1534. PubMed ID: 30589034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-related miRNA signature identifies prognosis and immune landscape in head and neck squamous cell carcinomas.
    Ma B; Li H; Qiao J; Meng T; Yu R
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33111959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six-gene signature for predicting survival in patients with head and neck squamous cell carcinoma.
    Wang J; Chen X; Tian Y; Zhu G; Qin Y; Chen X; Pi L; Wei M; Liu G; Li Z; Chen C; Lv Y; Cai G
    Aging (Albany NY); 2020 Jan; 12(1):767-783. PubMed ID: 31927533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-lncRNA expression signature predicts survival in head and neck squamous cell carcinoma (HNSCC).
    Wang P; Jin M; Sun CH; Yang L; Li YS; Wang X; Sun YN; Tian LL; Liu M
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30355656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
    Liu J; Lu J; Li W
    BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of TMB and the relationship between TMB and immune infiltration in head and neck squamous cell carcinoma: A gene expression-based study.
    Zhang L; Li B; Peng Y; Wu F; Li Q; Lin Z; Xie S; Xiao L; Lin X; Ou Z; Cai T; Rong H; Fan S; Li J
    Oral Oncol; 2020 Nov; 110():104943. PubMed ID: 32919362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
    Zhang F; Liu Y; Yang Y; Yang K
    BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
    Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
    Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel comprehensive immune-related gene signature as a promising survival predictor for the patients with head and neck squamous cell carcinoma.
    Fang R; Iqbal M; Chen L; Liao J; Luo J; Wei F; Wen W; Sun W
    Aging (Albany NY); 2021 Apr; 13(8):11507-11527. PubMed ID: 33867351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Prognostic 5-lncRNA Expression Signature for Head and Neck Squamous Cell Carcinoma.
    Liu G; Zheng J; Zhuang L; Lv Y; Zhu G; Pi L; Wang J; Chen C; Li Z; Liu J; Chen L; Cai G; Zhang X
    Sci Rep; 2018 Oct; 8(1):15250. PubMed ID: 30323196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Inflammation-Immunity Classifier of 11 Chemokines for Prediction of Overall Survival in Head and Neck Squamous Cell Carcinoma.
    Liang Y; Feng G; Zhong S; Gao X; Tong Y; Cui W; Huang G; Zhang Z; Zhou X
    Med Sci Monit; 2019 Jun; 25():4485-4494. PubMed ID: 31203306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression scoring of a small-nucleolar-RNA signature identified by machine learning serves as a prognostic predictor for head and neck cancer.
    Xing L; Zhang X; Zhang X; Tong D
    J Cell Physiol; 2020 Nov; 235(11):8071-8084. PubMed ID: 31943178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune-related genes have prognostic significance in head and neck squamous cell carcinoma.
    Yang J; Xie K; Li C
    Life Sci; 2020 Sep; 256():117906. PubMed ID: 32504750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Potential of Oxidative Stress Related Genes as Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma.
    Wang X; Zhou G
    Comb Chem High Throughput Screen; 2022; 25(11):1952-1965. PubMed ID: 34875987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel seven‑miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients.
    Lu L; Wu Y; Feng M; Xue X; Fan Y
    Mol Med Rep; 2019 Nov; 20(5):4340-4348. PubMed ID: 31545440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Metabolic Gene Signature to Predict Overall Survival in Head and Neck Squamous Cell Carcinoma.
    Wu ZH; Tang Y; Zhou Y
    Mediators Inflamm; 2020; 2020():6716908. PubMed ID: 33456371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.